.
MergerLinks Header Logo

New Deal


Announced

Completed

GIC and Baillie Gifford led a $350m Series C round in Solugen.

Financials

Edit Data
Transaction Value£254m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Venture Capital

United States

Biotechnology

Completed

biotechnology company

Cross Border

Private

Single Bidder

Acquisition

Friendly

Minority

Private Equity

Synopsis

Edit

GIC and Baillie Gifford led a $350m Series C round in Solugen, the company decarbonizing the chemicals industry, with participation from BlackRock, Carbon Direct Capital Management, Refactor Capital, and Fifty Years. "Our breakthroughs in enzyme and metal catalyst engineering allow us to produce chemicals in a more sustainable and profitable way. We can now deliver for our customers performance benefits, cost savings, and most importantly, lower carbon footprints," Gaurab Chakrabarti, Solugen CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US